Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Resilience
investment firm
About
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
- La Jolla,California,United States
- https://resilience.com
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $625M
- Industries
- Biopharma,Biotechnology,Health Care,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2020
- Operating Status
- Active
- Legal Name
- National Resilience, Inc.
- Also Known As
- National Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.The company is dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.It was founded in La Jolla, California in 2020.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$2.10B
Resilience has raised a total of
$2.10B
in funding over 2 rounds. Their latest funding was raised on
Jun 6, 2022 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 6, 2022 | Series D | $625M | — | — | — | Detail |
| Nov 22, 2021 | Series C | $80M | 1 | — | — | Detail |
| Aug 1, 2021 | Series C | $600M | — | — | — | Detail |
| Nov 23, 2020 | Series B | $750M | 6 |
8VC
ARCH Venture Partners
|
— | Detail |
| Oct 15, 2020 | Series A | $50M | 1 |
Magnetic Ventures
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
3
1
Resilience has made 3 investments. Their most recent investment was on
Nov 18, 2021, when Cellevolve Bio raised $6M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 18, 2021
Cellevolve Bio
|
Seed | $6M | Biotechnology | Yes |
|
Nov 5, 2021
bit.bio
|
Series B | $103M | Biotechnology | — |
|
Sep 23, 2021
Garuda Therapeutics
|
Series A | $72M | Biotechnology | — |
Investors
Number of Lead Investors
Number of Investors
3
6
Resilience is funded by 6 investors.
8VC
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
8VC
|
Yes | Series B |
|
ARCH Venture Partners
|
Yes | Series B |
|
Magnetic Ventures
|
— | Series C |
GV
|
— | Series B |
Lux Capital
|
— | Series B |
New Enterprise Associates
|
— | Series B |
Employee Profiles
Number of Employee Profiles
31
Resilience has 31 current employee profiles, including
Employee Michael Mylrea
Employee
Advisor
Board member
Board member
Board member
Acquisition
Resilience has acquired 2 organizations. Their most recent acquisition was Ology Bioservices on Apr 12, 2021. They acquired Ology Bioservices for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Apr 12, 2021
Ology Bioservices
|
Biotechnology | acquisition | — | Detail |
|
Dec 2, 2021
Swiftscale Biologics
|
Big Data | acquisition | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
